This study is testing if a new lozenge called APG-157 can safely shrink head and neck tumors before patients start their main cancer treatment, like surgery or radiation. Researchers want to see if reducing the tumor size first leads to better outcomes. The study involves 24 newl…
Phase: PHASE2 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC